CLINICAL_TRIALS
trial_result
· 2026-01-29
Clinical Trial Update: Imatinib for Pain in Sickle Cell Anemia [Phase 1, Phase 2]
Summary
A Phase 1/2 trial evaluating imatinib for pain in Sickle Cell Disease was terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-01-29